Maxcyte (DI) (MXCT)

Index:

FTSE AIM 100

165.50p
   
  • Change Today:
    -0.50p
  • 52 Week High: 405.00
  • 52 Week Low: 161.50
  • Currency: UK Pounds
  • Shares Issued: 106.32m
  • Volume: 12,386
  • Market Cap: £175.96m
  • Beta: 0.03

Maxcyte (DI) Overview

We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. We understand and scientifically solve partners’ challenges by applying our expertise.

1 Day Chart (15-05-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -132.5% -122.3%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.1 4.3
Pr/Book 1.1  
Latest F'cast
Revenue -6.4% -19.9%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Maxcyte (DI) Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 26.00 (11.82) (17.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 33.89 (19.08) (21.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 44.26 (23.57) (54.87)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 41.29 (37.92) (37.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-24 38.63 (41.06) (39.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Maxcyte (DI) Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 41.21 (50.40) (28.57)p n/a n/a n/a n/a 0.0%
31-Dec-26 49.91 (46.71) (25.86)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Maxcyte (DI) Company Announcements

Filing of Form 10-Q 09-May-2025 07:00 RNS
First Quarter 2025 Financial Results 08-May-2025 07:00 RNS
Total Voting Rights 02-May-2025 16:40 RNS

Maxcyte (DI) ShareCast News

MaxCyte signs SPL deal with TG Therapeutics 12-Feb-2025 ShareCast
MaxCyte announces acquisition of SeQure Dx 30-Jan-2025 ShareCast
MaxCyte flags full-year revenue at top end of ex... 13-Jan-2025 ShareCast

Latest Maxcyte (DI) Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Maxcyte (DI) Market Data

Currency UK Pounds
Share Price 165.50p
Change Today -0.50p
% Change -0.30 %
52 Week High 405.00
52 Week Low 161.50
Volume 12,386
Shares Issued 106.32m
Market Cap £175.96m
Beta 0.03

Maxcyte (DI) Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Maxcyte (DI) Dividends

No dividends found

Trades for 15-May-2025

Time Volume / Share Price
16:25 66 @ 161.50p
16:20 695 @ 162.00p
15:32 200 @ 162.00p
15:17 3 @ 170.00p
15:16 478 @ 164.00p

Top of Page